Epidemiology of Non-Alcoholic Fatty Liver Disease

被引:683
|
作者
Bellentani, Stefano [1 ]
Scaglioni, Federica [1 ]
Marino, Mariano [1 ]
Bedogni, Giorgio [1 ,2 ]
机构
[1] Azienda USL Modena, Ctr Studi Fegato, Carpi, Italy
[2] Ctr Studi Fegato, Trieste, Italy
关键词
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Epidemiology; HEPATIC STEATOSIS; METABOLIC SYNDROME; NATURAL-HISTORY; RISK-FACTORS; TRANSAMINASE ABNORMALITIES; HEPATOCELLULAR-CARCINOMA; INDEPENDENT PREDICTORS; INSULIN-RESISTANCE; CLINICAL-FEATURES; STEATOHEPATITIS;
D O I
10.1159/000282080
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20-30%. About 2-3% of the general population is estimated to have non-alcoholic steatohepatitis (NASH), which may progress to liver cirrhosis and hepatocarcinoma. As a rule, the prevalence of NAFLD is higher in males and increases with increasing age, and it is influenced by the diagnostic method and the characteristics of the population, especially lifestyle habits. Population-based studies provide better estimates of the prevalence of NAFLD as compared to autoptic and clinical studies, but few such studies have been performed to date. The diagnosis of NAFLD in population studies is usually obtained by ultrasonography, which is known to underestimate the prevalence of fatty liver. The Dallas Heart Study and the Dionysos Study reported that 30% of the adults in the USA and 25% in Italy have NAFLD. In these studies, 79% and 55% of patients with NAFLD had normal aminotransferase levels, showing that liver enzymes are not surrogate markers of NAFLD in the general population. Noninvasive markers such as the fatty liver index obtained from the Dionysos Study may be useful to screen for NAFLD in the general population. The most important risk factors for NAFLD are male gender, age, obesity, insulin resistance and the cardiometabolic alterations that define the metabolic syndrome. The prevalence of NAFLD is 80-90% in obese adults, 30-50% in patients with diabetes and up to 90% in patients with hyperlipidemia. The prevalence of NAFLD among children is 3-10%, rising up to 40-70% among obese children. Moreover, pediatric NAFLD increased from about 3% a decade ago to 5% today, with a male-to-female ratio of 2:1. The incidence and natural history of NAFLD are still not well defined, but it is recognized that the majority of individuals with NAFLD do not develop NASH. The incidence of NAFLD is probably increasing in Western countries, strictly linked to lifestyle habits. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:155 / 161
页数:7
相关论文
共 50 条
  • [11] Epidemiology of non-alcoholic and alcoholic fatty liver diseases
    Mitra, Souveek
    De, Arka
    Chowdhury, Abhijit
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [12] Epidemiology of non-alcoholic fatty liver disease in Asia
    Sui-Weng Wong
    Wah-Kheong Chan
    Indian Journal of Gastroenterology, 2020, 39 : 1 - 8
  • [13] Non-alcoholic fatty liver disease. How and who to screen
    Teran Lantaron, Alvaro
    Crespo Garcia, Javier
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (04): : 278 - 288
  • [14] Liver transplantation and non-alcoholic fatty liver disease
    Petros Zezos
    Eberhard L Renner
    World Journal of Gastroenterology, 2014, (42) : 15532 - 15538
  • [15] Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Pittaras, Andreas
    Faselis, Charles
    Narayan, Puneet
    Kokkinos, Peter
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (03) : 239 - 245
  • [16] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
  • [17] Non-alcoholic Fatty Liver Disease in Children
    Muzurovic, Emir
    Polyzos, Stergios A.
    Mikhailidis, Dimitri P.
    Borozan, Sanja
    Novosel, Dusanka
    Cmiljanic, Oleg
    Kadic, Natasa
    Mantzoros, Christos S.
    CURRENT VASCULAR PHARMACOLOGY, 2023, 21 (01) : 4 - 25
  • [18] Epigenetics in non-alcoholic fatty liver disease
    Lee, Jooho
    Kim, Yuri
    Friso, Simonetta
    Choi, Sang-Woon
    MOLECULAR ASPECTS OF MEDICINE, 2017, 54 : 78 - 88
  • [19] Non-alcoholic fatty liver disease and lipotoxicity
    Wasilewska, Natalia
    Lebensztejn, Dariusz Marek
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (01) : 1 - 6
  • [20] Lipidomics in non-alcoholic fatty liver disease
    Kartsoli, Sofia
    Kostara, Christina E.
    Tsimihodimos, Vasilis
    Bairaktari, Eleni T.
    Christodoulou, Dimitrios K.
    WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (08) : 436 - 450